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Abstract. 
 
The ER is uniquely enriched in chaperones 
and folding enzymes that facilitate folding and unfold-
ing reactions and ensure that only correctly folded and 
assembled proteins leave this compartment. Here we 
address the extent to which proteins that leave the ER 
and localize to distal sites in the secretory pathway are 
able to return to the ER folding environment during 
their lifetime. Retrieval of proteins back to the ER was 
studied using an assay based on the capacity of the ER 
to retain misfolded proteins. The lumenal domain of 
the temperature-sensitive viral glycoprotein 
VSVGtsO45 was fused to Golgi or plasma membrane 
targeting domains. At the nonpermissive temperature, 
newly synthesized fusion proteins misfolded and were 
retained in the ER, indicating the VSVGtsO45 
ectodomain was sufficient for their retention within the 
ER. At the permissive temperature, the fusion proteins 
were correctly delivered to the Golgi complex or 
plasma membrane, indicating the lumenal epitope of 
VSVGtsO45 also did not interfere with proper target-
ing of these molecules. Strikingly, Golgi-localized fu-
sion proteins, but not VSVGtsO45 itself, were found to 
redistribute back to the ER upon a shift to the nonper-
missive temperature, where they misfolded and were 
retained. This occurred over a time period of 15 min–2 h 
depending on the chimera, and did not require new 
protein synthesis. Significantly, recycling did not ap-
pear to be induced by misfolding of the chimeras within 
the Golgi complex. This suggested these proteins nor-
mally cycle between the Golgi and ER, and while pass-
ing through the ER at 40
 
8
 
C become misfolded and re-
tained. The attachment of the thermosensitive 
VSVGtsO45 lumenal domain to proteins promises to 
be a useful tool for studying the molecular mechanisms 
and specificity of retrograde traffic to the ER.
 
N
 
ewly 
 
synthesized proteins in the ER undergo dy-
namic folding/unfolding reactions as they fold and
assemble into functional protein complexes. Such
reactions are mediated by ER-specific chaperones and fold-
ing enzymes that help prevent nonproductive interactions
and irreversible aggregation of proteins (Rothman, 1989;
Gething and Sambrook, 1992). Because only correctly
folded proteins leave the ER and proceed to the Golgi
complex and beyond, whereas incompletely folded, mis-
folded, or unassembled proteins are retained and/or de-
graded, the ER serves an important “quality control” func-
tion in secretory traffic (Hurtley and Helenius, 1989; Doms
et al., 1993). Newly synthesized proteins are thereby kept
in contact with the extensive and efficient ER folding ma-
chinery until they are conformationally mature, whereas
nonfunctional and incomplete protein complexes gener-
ally have no access into the secretory pathway.
Given that the ER is the sole compartment that exhibits
these quality control functions, mechanisms that retrieve
proteins back to the ER could be important for monitor-
ing the fidelity of a wide variety of proteins that have left
this compartment. For example, unassembled class I mole-
cules exported from the ER have been found to cycle back
to the ER, whereas properly assembled class I molecules
are efficiently transported to the cell surface (Hsu et al.,
1991). The inventory of other proteins exported from the
ER that return to this quality control environment during
their lifetime (to undergo possible further modifications
and/or degradation) is still incomplete. Many membrane
proteins that function at the interface of the ER and Golgi
complex, for example, have been found to constitutively
cycle between the ER and the Golgi complex. These pro-
 
teins include: the KDEL receptor (KDELR)
 
1
 
, which re-
trieves soluble ER resident proteins that have escaped into
the secretory pathway (Semenza et al., 1990; Lewis and
Pelham, 1992); vesicle 
 
N
 
-ethylmaleimide–sensitive factor
attachment protein receptors v-SNAREs involved in ER
to Golgi transport (Rothman, 1994; Lewis and Pelham,
1996); and putative cargo receptors, such as the mannose-
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binding protein endoplasmic reticulum–Golgi intermediate
compartment (ERGIC)53/p58 (Arar et al., 1995; Itin et al.,
1996; Lahtinen et al., 1996), the yeast Emp47p (Schroder
et al., 1995), and p24 family members (Schimmoller et al.,
1995; Blum et al., 1996). Golgi to ER retrograde trafficking
of these proteins could reflect a highly selective process, or
alternatively represent a generalized bulk recycling system.
To study the capacity of proteins targeted to the Golgi
complex and beyond to return to the folding environment
of the ER, we used a well-studied thermoreversible fold-
ing mutant of vesicular stomatitis virus (VSV) G protein
called tsO45. At 40
 
8
 
C, VSVGtsO45 misfolds, forms nonco-
valently associated aggregates, and is retained within the ER
(Doms et al., 1987, 1988; Hurtley and Helenius, 1989). When
the temperature is lowered to 32
 
8
 
C, the aggregates rapidly
disassemble, VSVGtsO45 subsequently trimerizes, and then
it exits the ER with normal kinetics (Balch et al., 1986;
Doms et al., 1987). Importantly, VSVGtsO45 that has exited
the ER is no longer thermosensitive (Balch and Keller,
1986; deSilva et al., 1990), whereas VSVGtsO45 delivered
back to the ER can reaggregate at 40
 
8
 
C (Doms et al., 1989;
de Silva et al., 1990). These properties make VSVGtsO45
a potentially useful tool for studying the mechanisms that
underlie retention in and retrieval to the folding/misfold-
ing environment of the ER.
We focus here on fusion proteins upon which the tem-
perature-sensitive lumenal ectodomain of VSVGtsO45 has
been appended to different Golgi or plasma membrane tar-
geting proteins/domains, including the KDELR (Hsu et al.,
1992), a KDELR mutant (KDELRm; Townsley et al., 1993),
TGN38 (Luzio et al., 1990) and the 
 
a
 
 chain of the interleu-
kin-2 receptor (IL2R; Leonard et al., 1984). Addition of
the VSVGtsO45 ectodomain was shown to be sufficient to
retain the fusion proteins in the ER at 40
 
8
 
C, where they re-
mained misfolded. At the permissive temperature of 32
 
8
 
C,
the fusion proteins correctly localized to the Golgi com-
plex or plasma membrane, indicating that the lumenal
epitope of VSVGtsO45 did not interfere with their proper
targeting. Remarkably, when cells were shifted from 32
 
8
 
back to 40
 
8
 
C, the Golgi-localized proteins reaccumulated
within the ER due to misfolding of the G protein ectodomain.
These redistributions did not require new protein synthesis
and did not appear to be induced by misfolding of the chi-
meras within the Golgi complex. Rather, the chimeras ex-
hibited a misfolded phenotype only after their redistribution
into the ER. These data suggest that the Golgi-targeted,
VSVG fusion proteins undergo constitutive recycling to the
ER where they are reexposed to the ER folding machinery.
Under conditions when these proteins misfold (i.e., 40
 
8
 
C),
they become retained/trapped in the ER, and thereby lose
their normal Golgi localization. Additional experiments
with VSVGtsO45 that contained a shortened transmem-
brane domain suggested such Golgi to ER retrograde traf-
fic is not exclusively signal mediated and may be an inherent
property of proteins localized to Golgi membranes.
 
Materials and Methods
 
Plasmids
 
For expression in COS cells, constructs were generated in the SV40-based
vector pSVGL3, which contained VSVGtsO45 as a reciprocal recombinant
 
called C-D/R-ts (provided by J. Rose, Yale University, New Haven, CT;
Gallione and Rose, 1985). Unique Sac I–BamHI restriction sites were
used to replace the transmembrane domain and cytoplasmic tail of
VSVGtsO45 with the appropriate inserts. VSVG–KDELR wild type was
created by subcloning a full-length human homologue of the KDELR,
ELP1 (from V. Hsu, Harvard Medical School, Boston, MA; Hsu et al.,
1992), into C-D/R-ts. This chimera was made in-frame with tsO45 by di-
gesting with SacI–NotI, blunting the overhanging ends with T4 polymerase,
and religating. This generated a spacer region between the lumenal do-
main of tsO45 and ELP1 containing the amino acids GRFKGTDFLQDF.
A myc epitope was attached to the 3
 
9
 
 end of ELP1 (Hsu et al., 1992). All
other constructs were generated by subcloning PCR-amplified products
using appropriate primers directly into SacI–BamHI digested C-D/R-ts.
VSVG–KDELR mutant contained the full-length ELP1 coding sequence
with a single aspartic acid to asparagine mutation at position 195 (pro-
vided by V. Hsu). This is analogous to the Asp to Asn mutation at position
193 in the human KDELR, hERD2 (Townsley et al., 1993). This construct
contained a hemagglutinin (HA) epitope after ELP1. VSVG–TGN38 con-
tained the transmembrane domain and cytoplasmic tail (amino acids 304–
357) of TGN38 (provided by J. Bonifacino, National Institutes of Health
[NIH] Bethesda, MD; Luzio et al., 1990). VSVG–IL2R contained the
transmembrane domain and cytoplasmic tail (amino acids 241–272) of the
 
a
 
 chain of the IL2 receptor, or Tac (provided by J. Bonifacino; Leonard et
al., 1984), followed by a HA epitope. VSVG–Leu15 contained a trans-
membrane segment of 15 leucines (following two serines derived from the
transmembrane domain of tsO45), followed by two lysines, and then the
entire cytoplasmic tail of tsO45. VSVG wild-type–TGN38 was created us-
ing the wild-type VSVG template, C-D/ts-R (Gallione and Rose, 1985). For
expression in CHO cells, inserts were subcloned into the expression vec-
tor pCDM8.1 (Marks et al., 1996). A cDNA coding for mouse 
 
a
 
-mannosi-
dase II was provided by K. Moreman (University of Georgia, Athens, GA)
and subcloned into the expression vector pCDLSRa. A cDNA for coding
for furin in pCDLSRa was provided by N. Wolins (NIH, Bethesda, MD)
and J. Bonifacino.
An attempt was made to fuse the lumenal domain of VSVGtsO45 onto
the cytoplasmic tail and transmembrane domain of the type II Golgi resi-
dent protein mannosidase II. However the resulting construct, mannosi-
dase II (Man II)-VSVGtsO45 misfolded and was retained within the ER
at all temperatures.
 
Cell Lines, Antibodies, and Reagents
 
COS-7 cells were maintained in DME (Biofluids, Inc., Rockville, MD)
supplemented with 10% FBS, 2 mM glutamate, 100 U/ml penicillin, and
100 
 
m
 
g/ml streptomycin (complete medium) at 37
 
8
 
C in a 5% CO
 
2
 
 incuba-
tor. CHO cells were maintained similarly in RPMI 1640 complete medium
(as above).
The following antibodies were used: rabbit polyclonal anti-VSV antise-
rum (provided by C. Machamer, Johns Hopkins University, School of
Medicine, Baltimore, MD); conformation-specific mouse monoclonal
anti-VSVG antibodies (I1 [8G5F11] and I14 [1E9F9]; provided by D.
Lyles, Wake Forest University, Winston-Salem, NC; Lefrancois and Lyles,
1982); rabbit polyclonal antibodies to mannosidase II (provided by K.
Moreman); mouse monoclonal anti–mannosidase II antibody (53FC3;
provided by B. Burke, University of Calgary, Calgary, Alberta, Canada);
rabbit polyclonal anti-ribophorin antiserum (provided by G. Kreibich,
New York University Medical Center, New York, NY); polyclonal antise-
rum versus ER membrane proteins (provided by D. Louvard, Institute
Curie, Paris, France); rabbit polyclonal antiserum versus GM130 (pro-
vided by G. Warren, Imperial Cancer Research Fund, London, England);
rabbit polyclonal antiserum versus furin (provided by E. Dell’Angelica,
NIH, Bethesda, MD and J. Bonifacino); rabbit polyclonal anti–
 
b
 
-coat pro-
tein (COP) antiserum; and mouse monoclonal antibodies against epitopes
in Myc (9E10; provided by J. Humphrey, NIH, Bethesda, MD) and HA
(HA.11; from BAbCO, Richmond, CA). FITC and rhodamine-conju-
gated secondary antibodies specific for mouse or rabbit immunoglobulins
were purchased from Southern Biotechnologies (Birmingham, AL).
Brefeldin A (BFA) was obtained (Epicentre Technologies, Inc., Madi-
son, WI) and stored as 1-mg/ml stock solutions in methanol. Cyclohexi-
mide (Sigma Chemical Co., St. Louis, MO) was stored as 10-mg/ml stock
solutions in water. 50 mM 2-deoxy-glucose/0.02% sodium azide was used
to deplete cellular ATP levels (Donaldson et al., 1991). AlF
 
4
 
, an activator
of heterotrimeric G proteins, was generated from 30 mM sodium fluoride
and 50 
 
m
 
M AlCl
 
3
 
 (Donaldson et al., 1991). Forskolin (Sigma Chemical
Co.) is a competitive antagonist of BFA, and was used at 100 
 
m
 
M (Lippin- 
Cole et al. 
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cott-Schwartz et al., 1991). 
 
N
 
-(6-aminohexyl)-5-chloro-1-naphthalene-
sulfonamide (W7), is a calmodulin antagonist that has been hypothesized
to be an inhibitor of membrane tubulation (used at 10 
 
m
 
M; deFigueiredo
and Brown, 1995). Wortmannin, an inhibitor of phosphatidylinositol (PI)-3
kinase has been shown to disrupt trafficking of lysosomal enzymes by in-
terfering with sorting in the TGN (used at 1 
 
m
 
M; Brown et al., 1995). Con-
canamycin B (used at 25 nM) is an inhibitor of vacuolar proton-ATPases,
and has been shown to alter secretory pathway function (Yilla et al., 1993;
data not shown). Monensin, a monovalent cation ionophore that blocks
transport through the Golgi complex (Tartakoff, 1983), was used at 30
 
m
 
M. All drugs were purchased from Sigma Chemical Co. Concanamycin
B was provided by J. Bonifacino.
 
Transfection and Immunofluorescence Microscopy
 
COS-7 cells were transiently transfected by calcium phosphate precipita-
tion for 16 h, washed once in PBS, and then incubated in complete me-
dium for an additional 24 h. Transfections were performed at either 40
 
8
 
 or
32
 
8
 
C as indicated. Stable transfectants in CHO cells were generated and
selected in 500 
 
m
 
g/ml G418 (Geneticin; GIBCO BRL, Gaithersburg, MD).
Cell fixation and antibody staining was performed according to Cole et al.
(1996). Cells were analyzed on a photomicroscope (model III; Carl Zeiss,
Inc., Thornwood, NY) using a 63
 
3
 
 Planapo lens (NA 1.4), and photogra-
phy was performed using Tri-X-pan ASA 400 film (Eastman Kodak,
Rochester, NY). For analyzing conformation-specific anti-VSVG antibod-
ies by immunofluorescence, cells were processed as above, except that
cells were fixed at 32
 
8
 
 or at 40
 
8
 
C for 5 min before moving to room temper-
ature.
Confocal images were acquired on a confocal laser scanning micro-
scope (model LSM 410; Carl Zeiss, Inc.), equipped with a triple line Ar/Kr
laser with a 100
 
3
 
 1.4 NA Planapochromat oil immersion objective. Each
image represents a single averaged (16-line-scan) image collected within
the linear range of fluorescence intensity based on the standard table pro-
vided with the imaging software. Image overlays represent samples ac-
quired using the sequential mode for double-label collection.
 
Flow Cytometry
 
For assaying cell surface expression of VSVGtsO45 chimeras, COS-7 cells
were transiently transfected at 40
 
8
 
C with 5 
 
m
 
g of chimeric plasmids into
duplicate wells of six-well dishes (Costar Corp., Cambridge, MA). After
36–40 h, 20 mM Hepes, pH 7.4, buffer and 50 
 
m
 
g/ml cycloheximide were
added to each well and the dishes were moved to an 18
 
8
 
C water bath for 3 h,
and then returned to the 40
 
8
 
C incubator for an additional 2 h. The cells
were released from the dishes with 15 mM EDTA/PBS, washed with 10%
serum/PBS, gently pelleted, and then placed on ice. For surface staining,
samples from one of the duplicate wells were bound to anti-VSVG mono-
clonal antibodies (a mixture of I1 and I14 antibodies), followed by FITC
goat anti–mouse secondary antibodies, both in the absence of saponin.
Cells were washed, fixed in 2% formaldehyde/PBS, washed again, and
then resuspended in PBS. For analysis of total staining, cells from the sec-
ond duplicate well were fixed in 2% formaldehyde/PBS for 30 min on ice,
washed, and then incubated with primary and secondary antibodies in the
presence of 0.2% saponin. Surface and total cellular fluorescence was
quantitated by flow cytometry on a FACScan
 
®
 
 (Becton and Dickinson
Co., Mountain View, CA) using CyQuest software. The analysis shown
was gated (M1) for surface expression of cells expressing parental
VSVGtsO45 released from 40
 
8
 
 to 32
 
8
 
C for 2 h. Kolmogorov–Smirnov sta-
tistical analysis was performed to determine that the plots generated were
significantly different, at 
 
P
 
 
 
, 
 
0.001 (Young, 1977).
 
Metabolic Labeling
 
For metabolic labeling of transiently transfected COS cells, subconfluent
monolayers grown in six-well dishes (Costar Corp.) were incubated in sus-
pension in methionine-free DME containing 3% dialyzed FBS for 30 min
at 40
 
8
 
C. Cells were pulse labeled with 250–750 
 
m
 
Ci/ml Tran
 
35
 
S-label (ICN
Biomedicals Inc., Costa Mesa, CA) or EXPRE35SS (NEN Life Science
Products, Boston, MA) for the times indicated, washed, and then chased
in complete medium containing 15 
 
3
 
 excess methionine and cysteine for
the times indicated. Aliquots of cells were collected at each time point.
 
Immunoprecipitation
 
For pulse-chase analysis in COS cells, metabolically labeled proteins were
immunoprecipitated and processed according to Cole et al. (1996). Pro-
 
teins were denatured by boiling for 5 min in 0.5% SDS/1.0% 
 
b
 
-mercapto-
ethanol, brought to 50 mM sodium citrate, pH 5.5, and then either mock
treated or treated with endoglycosidase H (endo H; 30 U/
 
m
 
l; New En-
gland Biolabs Inc., Beverly, MA), or a combination of endo H and
Neuraminidase (0.2 mU/
 
m
 
l; Boehringer Mannheim Biochemicals, India-
napolis, IN) for 4–16 h at 37
 
8
 
C. Samples were boiled with reducing sample
buffer and analyzed by 8% SDS-PAGE. After fixation, gels were treated
for fluorography with 1 M salicylate, dried, and then exposed to XAR-5
film (Eastman Kodak). For misfolding analysis in COS cells, cells were
processed as above, except that cells were solubilized by adding Triton
X-100 (1% final) plus protease inhibitors directly to the samples, and then
incubating at 32
 
8
 
 or 40
 
8
 
C for 1 min before placing on ice.
 
Cell Fractionation and In Vitro Misfolding
 
Briefly, COS 7 cells were grown to 70–80% confluency 2 d after transfec-
tion. Cells were scraped and labeled in suspension with 1 mCi/ml Tran
 
35
 
S-
label (ICN Biomedicals Inc.) for 75 min, and then chased in unlabeled me-
dium for 75 min at 32
 
8
 
C. All further cell homogenization and fractionation
procedures were performed at 4
 
8
 
C, according to Yang et al. (1997). Mem-
brane pellets were analyzed for galactosyltranferase activity (Bole et al.,
1986), and then Western blotted with antibodies to ribophorin, to identify
fractions containing Golgi and ER membranes, respectively.
Fractions 4–8 (ER) and 13–18 (Golgi) were pooled, split into equal parts,
and then pelleted at 125,000 
 
g
 
 for 1 h. Membrane pellets were resus-
pended in homogenization buffer plus protease inhibitors, incubated at
32
 
8
 
 or 40
 
8
 
C for the indicated times, and then lysed by adding 2 
 
3
 
 lysis
buffer (homogenization buffer plus 2% Triton X-100, 20 mM NEM) for
2 min at the indicated temperature, before placing on ice. Lysates were
immunoprecipitated either with polyclonal anti-VSV antisera or confor-
mation-specific I14 antibodies. Precipitates were analyzed by reducing 8%
SDS-PAGE, and then scanned by densitometry (ImageQuant; Molecular
Dynamics, Inc., Sunnyvale, CA).
 
Cycloheximide Treatment
 
In the recycling assay presented here, cycloheximide was used at concen-
trations of 50–100 
 
m
 
g/ml in COS cells, and 10 
 
m
 
g/ml in CHO cells. This
was sufficient to inhibit protein synthesis 
 
z
 
90%. We found, however, that
cycloheximide concentrations that inhibit protein synthesis 
 
.
 
95% could
effectively prevent retention of the redistributed VSVG chimeras in the
ER at 40
 
8
 
C. It appears that subtle changes in protein synthesis can have
profound consequences on the ER retention machinery. Although this
does not affect the results presented here, this may be the likely explanation
for escape of VSVGtsO45 from the ER at 40
 
8
 
C in CHO cells with high
levels of viral infection (data not shown; Hammond and Helenius, 1994).
 
Results
 
Construction of VSVGtsO45 Fusion Proteins
 
VSVGtsO45 contains a single amino acid change within its
lumenal domain that leads to its misfolding and retention
within the ER at 40
 
8
 
, but not at 32
 
8
 
C (Gallione and Rose,
1985). To study quality control features of the secretory path-
way such as retention in and retrieval to the ER, we at-
tached the thermosensitive lumenal domain of VSVGtsO45
to proteins and/or targeting domains that normally direct
localization to the Golgi complex or plasma membrane
(Fig. 1). These included: the KDELR, a Golgi protein that
recycles escaped KDEL-containing ligands from the Golgi
to the ER (Lewis and Pelham, 1992); KDELR mutant
(KDELRm), a recycling-defective form of KDELR (Towns-
ley et al., 1993); the transmembrane domain and cytoplas-
mic tail of TGN38, a protein characteristic of the TGN
(Humphrey et al., 1993); and the transmembrane domain
and cytoplasmic tail of the 
 
a
 
 chain of the IL2R, which
functions in IL2 uptake at the cell surface (Leonard et al.,
1984). We also replaced the transmembrane domain of
VSVGtsO45 with a synthetic stretch of 15 leucine resi- 
The Journal of Cell Biology, Volume 140, 1998 4
 
dues, which previously has been shown to cause Golgi ac-
cumulation of proteins normally destined to the plasma
membrane (Munro, 1995).
 
Expression and Localization of VSVG Fusion Proteins
 
The cellular distributions and biochemical modifications
of VSVGtsO45 and each of the fusion proteins were char-
acterized in transfected COS cells by indirect immunofluo-
rescence microscopy using polyclonal anti-VSV antiserum.
At the nonpermissive temperature of 40
 
8
 
C, each of the
chimeras, as well as parental VSVGtsO45, showed a retic-
ular ER-like pattern with nuclear envelope staining (Fig.
2, 
 
left
 
), which coincided with labeling of endogenous ER
membrane proteins (data not shown). Metabolic pulse-
chase labeling experiments of transfected cells maintained
at 40
 
8
 
C revealed that fusion proteins remained sensitive to
endo H digestion (Fig. 3, 
 
right
 
), suggesting they were not
transported out of the ER into the secretory pathway at
40
 
8
 
C where their 
 
N
 
-linked glycans would be modified by
Golgi enzymes. Therefore, the VSVGtsO45 lumenal do-
main appeared to be sufficient for retention of the fusion
proteins in the ER at 40
 
8
 
C, consistent with the tempera-
ture-induced folding defect demonstrated for VSVGtsO45
(Doms et al., 1987).
Whether the appended VSVGtsO45 ectodomain could
properly fold and permit targeting of the chimeras to their
predicted destinations was tested in COS cells transfected
at 32
 
8
 
C (Fig. 2, 
 
right
 
). At this temperature, VSVG–KDELR
localized predominantly to the Golgi complex with moder-
ate amounts of ER staining. The VSVG–KDELR mutant
chimera, by contrast, gave an exclusively Golgi staining
pattern when expressed at 32
 
8
 
C, without associated ER stain-
ing. Overexpression of KDEL-containing molecules at 32
 
8
 
C
induced the redistribution of the KDELR wild-type, but
not mutant, chimera into the ER (data not shown). This is
consistent with the results of Townsley et al. (1993), and
suggests that the G protein ectodomain does not interfere
with KDELR function (Lewis and Pelham, 1992). VSVG–
TGN38 was similarly targeted to the Golgi complex at 32
 
8
 
C,
and could be redistributed to the cell surface by over-
expression of other TGN-targeted molecules, similar to re-
sults of Humphrey et al. (1993) for TGN38 (data not shown).
 
The steady-state Golgi distributions of the above chime-
ras persisted in cells treated with cycloheximide, which
blocks new protein synthesis, indicating they were stably
maintained within Golgi membranes. This contrasted with
VSVGtsO45, VSVG–IL2R, and VSVG–Leu15, which were
delivered to the plasma membrane at 32
 
8
 
C, although with
different efficiencies. There was a significant accumulation
of the Leu15 (and to a lesser extent IL2R) chimera in the
Golgi complex (Fig. 2, 
 
right
 
), but this pool could be com-
pletely chased to the plasma membrane with cyclohexi-
mide treatment after several hours (data not shown). This
suggested that insertion of the Leu15 transmembrane do-
main slowed transport of VSVG through the Golgi com-
plex, rather than specifically targeting the fusion protein to
the Golgi complex (Munro et al., 1995).
In metabolically labeled cells pulsed at 40
 
8
 
, and then
chased at 32
 
8
 
C for 2 h, the vast majority of the VSVG–
KDELR remained sensitive to endo H (Fig. 3). By con-
trast, 
 
z
 
50% of the VSVG–KDELRm acquired endo H
resistance and neuraminidase sensitivity, suggesting this
chimera has access to the 
 
trans
 
-most processing enzymes
of the Golgi complex. VSVG–TGN38 gave a more com-
plex carbohydrate processing pattern with several endo
H–resistant bands, including partial sensitivity to neuramini-
dase. Although the reason for the lack of complete pro-
cessing of these chimeras is unclear, these results suggest
that the KDELRm and TGN38 chimeras become more ac-
cessible to distal Golgi processing enzymes than the KDELR
wild-type chimera. Both VSVG–Leu15 and VSVG–IL2R
became partially endo H resistant and neuraminidase sen-
sitive (Fig. 3), and were fully processed upon longer chase
periods (data not shown), similar to parental VSVGtsO45.
Laser scanning confocal microscopy was used to com-
pare the distributions of the VSVG chimeras with other
well-characterized Golgi markers (see Nilsson et al., 1993;
Shima et al., 1997). Transfected cells were maintained at
32
 
8
 
C, treated with cycloheximide for 3 h, fixed, and la-
beled with appropriate primary and secondary antibodies,
and then optical sections were analyzed. Fig. 4 shows dif-
ferences in distributions revealed by overlay images from
single optical sections (depth of field is 
 
z
 
0.4 
 
m
 
m). The dis-
tribution of each of the chimeras extended throughout the
Golgi complex, as evidenced by partial colocalizations with
Figure 1. Schematic repre-
sentation of VSVGtsO45 chi-
meras. The temperature-sen-
sitive lumenal domain of
VSVGtsO45 was fused in-
frame with (left to right): a
full-length human homo-
logue of the KDELR
(VSVG–KDELR; Hsu et al.,
1992); a full-length mutant
form of the KDELR, which contains a single amino acid change (Asp to Asn at position 195) that fails to redistribute into the ER upon
overexpression of KDEL-containing ligands, and is presumably recycling defective (analogous to Townsley et al., 1993); the transmem-
brane domain and cytoplasmic tail of TGN38 (Luzio et al., 1990), which contain nonoverlapping domains sufficient to confer steady-state
TGN localization (Humphrey et al., 1993; Ponnambalam et al., 1994); the transmembrane domain and cytoplasmic tail of the cell sur-
face protein, the a chain of the IL2R (Leonard et al., 1984); and a construct in which the transmembrane domain of VSVGtsO45 was
replaced by a synthetic transmembrane domain composed of 15 leucines. This has been shown to result in accumulation within the
Golgi complex of proteins normally destined for the plasma membrane (Munro, 1995). The quaternary structures of these constructs
have not been analyzed, yet we assume that VSVG–TGN38, VSVG–IL2R, and VSVG–Leu15 form trimers, since it is the lumenal domain
of VSVGtsO45 that is responsible for trimer formation (Doms et al., 1988). The oligomeric nature of KDELR is not known. 
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the 
 
cis
 
-Golgi membrane protein GM130 (Nakamura et al.,
1995), the medial Golgi enzyme mannosidase II (Ra-
bouille et al., 1995), and the TGN marker, furin (Bosshart
et al., 1994). However, clear gradations of distribution ex-
isted, even in transiently expressing cells. VSVG–KDELR
showed the greatest degree of overlap with GM130 and
mannosidase II, although it can be seen to extend into the
TGN, whereas VSVG–KDELRm and VSVG–TGN38 were
significantly concentrated within the TGN (see overlay
with furin), with less accumulation in the proximal regions
of the Golgi (GM130 and mannosidase II).
Taken together, these results show that addition of even
full-length proteins to the ectodomain of VSVGtsO45 per-
mitted not only the proper thermoreversibility of the G
protein ectodomain, but the proper targeting specificity
dictated by the attached molecules and/or domains.
 
Retrograde Transport of Golgi-localized VSVG
Fusion Proteins
 
To study whether VSVG fusion proteins ever return to the
Figure 2. Localization of VSVGtsO45 chimeras at nonpermissive
(408C) and permissive (328C) temperatures. COS cells were tran-
siently transfected with the indicated constructs and maintained
at either 408 or 328C. After 40 h, cells were fixed, permeabilized,
and prepared for indirect immunofluorescence using polyclonal
anti-VSV antibodies followed by rhodamine anti–rabbit second-
ary antibodies. At 408C, VSVGtsO45, as well as each of the chi-
meras, were retained in the ER (left), whereas at 328C, the con-
structs were distributed to the Golgi complex and/or the plasma
membrane (right). b-COP staining (bottom) indicates the distri-
bution of the Golgi complex, and was from cells double labeled
for VSVG–Leu15. Bar, 10 mm.
Figure 3. Processing of VSVG chimeras at nonpermissive and per-
missive temperatures. COS cells were pulse labeled with [35S]me-
thionine for 20 min at 408C, and then chased at 328C in unlabeled
medium for 2 h, or maintained at 408C for 4 h. The cells were de-
tergent solubilized and immunoprecipitated with anti-VSVG an-
tibodies. Immunoprecipitates were treated with or without endo
H or a combination of endo H and neuraminidase (endo H/NA)
before analysis by SDS-PAGE under reducing conditions. Note
the increase in mobility for tsO45 and several of the chimeras when
treated with endo H/neuraminidase. Complete processing for the
Leu15 and IL2R chimeras occurred during longer chase periods.The Journal of Cell Biology, Volume 140, 1998 6
folding environment of the ER once transported into the
Golgi complex, we examined the effect of a temperature
shift to 408C on the distribution of Golgi-localized chimeras.
Assuming the ER is the only compartment where misfold-
ing of proteins leads to their retention (Hurtley and Hele-
nius, 1989), any of the Golgi-localized fusion proteins that
recycled to the ER would be predicted to become mis-
folded and trapped there over time in cells shifted to 408C.
Cells transfected with VSVGtsO45 or the various chi-
meras at 408C were shifted to 328C for 2 h (for VSVG–
KDELR, VSVG–KDELRm, and VSVG–TGN38), or to
188C for 3 h (for VSVGtsO45, VSVG–IL2R, and VSVG–
Leu15) to accumulate these proteins within the Golgi com-
plex (Fig. 5, left). Cells were then shifted to 408C for 2 h,
fixed, and then examined by immunofluorescence micros-
copy. As shown in Fig. 5 (middle), whereas VSVGtsO45
and VSVG–IL2R were primarily transported to the plasma
membrane after a shift to 408C, VSVG–KDELR, VSVG–
KDELRm, and VSVG–TGN38 redistributed into the ER.
VSVG–Leu15 showed an intermediate ER/plasma mem-
brane distribution. Double labeling with antibodies to man-
nosidase II (Fig. 5, bottom row), or to the peripheral Golgi
coat protein, b-COP (data not shown) showed that redis-
tribution of the fusion proteins into the ER at 408C did not
affect the distribution of other Golgi proteins or disrupt
the organization of the Golgi complex. In addition, a wild-
type VSVG–TGN38 chimera (whose lumenal domain was
not thermosensitive for misfolding) showed no change in
its Golgi localization in cells shifted to 408C (data not shown),
indicating the redistributions were specific for fusion pro-
teins containing the tsO45 mutation.
Several observations suggested that the accumulation of
the fusion proteins within the ER reflected their retro-
grade transport into the ER, rather than degradation of
the Golgi-localized proteins and ER retention of newly
synthesized pools at 408C. First, redistribution of the fu-
sion proteins into the ER occurred in the absence of new
protein synthesis, since transfected cells treated with 50–
100 mg/ml cycloheximide (sufficient to inhibit protein syn-
thesis in these cells by 85–90%) gave the same pattern and
kinetics of redistribution as untreated cells (data not shown).
Second, there was no evidence for a significant loss of ma-
terial during the temperature shift as revealed from pulse-
chase/immunoprecipitation experiments (see Fig. 9). Fi-
nally, in biochemical assays with organelles that had been
separated by gradient fractionation, the percentage of
metabolically labeled VSVG–TGN38 in Golgi membranes
decreased in cells shifted from 328 to 408C for 2 h, with a
corresponding increase in ER-enriched fractions (data not
shown).
Cells expressing the KDELR, KDELRm, and TGN38
chimeras that were shifted to 408C showed normal Golgi
staining patterns when subsequently returned to 328C (Fig.
5, right). Thus, the ER accumulation phenotype of these
proteins is fully reversible. These results indicate that it is
possible to trap and accumulate within the ER at 408C
tsO45-containing proteins that have been recycled from all
Golgi compartments.
Kinetics and Properties of Retrograde Transport
To compare the kinetics of redistribution into the ER for
the different Golgi resident chimeras, cells maintained at
328C were shifted to 408C for various lengths of time, fixed,
and then examined by immunofluorescence microscopy.
The length of time at 408C necessary to redistribute each
of the chimeras completely back into the ER was then de-
termined and was used to estimate recycling kinetics. VSVG–
KDELR redistributed into the ER with a t1/2 of z20 min,
whereas VSVG–TGN38 and VSVG–KDELRm redistrib-
uted more slowly (t1/2, z60 and z75 min, respectively).
Thus, each of the fusion proteins exhibited a distinct rate
of transport to the ER, which appeared to be fastest for
proteins localized in the cis-most regions of the Golgi and
slower for proteins localized in the trans-Golgi/TGN.
Several drug treatments were found to inhibit redistri-
bution of the VSVGtsO45 fusion proteins into the ER upon
a temperature shift from 328 to 408C. These included: ATP
Figure 4. Colocalization of VSVG chime-
ras with Golgi markers by immunofluores-
cence microscopy. COS cells transfected at
328C with the indicated chimeras and indi-
cated Golgi marker proteins (GM130
shows endogenous protein) were treated
with cycloheximide for 3 h, fixed, and then
double labeled with antibodies to VSVG
(left) and Golgi proteins (top) followed by
FITC-coupled (VSVG) and rhodamine-
coupled (Golgi marker) secondary anti-
bodies. Each panel shows an overlay im-
age, with yellow indicating the region of
overlap. Bar, 5 mm.Cole et al. Retrograde Transport from the Golgi to the ER 7
depletion with 2-deoxy-glucose/sodium azide; AlF4, an ac-
tivator of heterotrimeric G proteins; forskolin, an antago-
nist of BFA; W7, a calmodulin antagonist; wortmannin, a
phosphatidylinositol-specific kinase inhibitor; concanamy-
cin B, an inhibitor of vacuolar proton-ATPases; and the
Na1 ionophore, monensin (Table I; refer to Materials and
Methods). CHO cells stably expressing VSVG–TGN38 were
incubated at 328C to accumulate the chimera in the Golgi
complex, and again for an additional 10 min with the indi-
cated drugs at 328C before shifting to 408C for 2 h. Cells
Figure 5. Membrane cycling dynamics of
VSVG chimeras. COS cells transfected at
408C were shifted to either 188C for 3 h
(VSVGtsO45, IL2R, and LEU15 chime-
ras), or to 328C for 2 h (KDELR wild type,
KDELRm, and TGN 38 chimeras; left),
and then shifted to 408C for 2 h (middle
column), before shifting back to 328C for
an additional 2 h (right). Cells were fixed,
permeabilized, and prepared for immun-
ofluorescence microscopy using anti-VSV
antibodies. The Golgi complex was visual-
ized with antibodies to cotransfected
a-mannosidase II (Man II), followed by
FITC-labeled anti–mouse secondary anti-
bodies (bottom). The panels showing man-
nosidase II staining correspond to cells
double labeled for VSVG–TGN38.
Whereas VSVGtsO45, VSVG-IL2R and
some VSVG-Leu15 were delivered to the
plasma membrane upon a shift to 408C
(middle column), the KDELR wild type,
KDELRm, and TGN38 chimeras had re-
distributed into the ER. Mannosidase II
staining was generally unaffected by the
temperature shift, although a slight in-
crease in ER staining can often be seen.
Notice the presence of Golgi staining with
the Leu15 and IL2R chimeras, but not
VSVGtsO45, after a return to 328C (right).
Bar, 10 mm.The Journal of Cell Biology, Volume 140, 1998 8
were fixed and then examined by immunofluorescence mi-
croscopy. All of the above treatments, excluding the iono-
phore monensin, effectively prevented redistribution of
VSVG–TGN38 into the ER at 408C without changing its
Golgi distribution. This was compared with the redistribu-
tion of Golgi membranes into the ER by BFA (Doms et
al., 1989; Lippincott-Schwartz et al., 1989). Interestingly,
all of the above treatments, including monensin, also in-
hibited retrograde transport of VSVG–TGN38 into the
ER with BFA (Table I). Although the molecular mecha-
nisms through which these compounds prevent retrograde
traffic are unclear, these results suggest that membrane
pathway(s) from the Golgi to the ER, followed by the fu-
sion proteins during temperature shifts and BFA treat-
ment, share similar, but not identical, properties.
Recycling of Itinerant VSVG Fusion Proteins
Although VSVGtsO45 was delivered exclusively to the
cell surface when shifted to 408C after first being accumu-
lated in the Golgi complex (Fig. 5, middle), a significant
proportion of VSVG–Leu15 and VSVG–IL2R, most no-
ticeably VSVG–Leu15, had indeed redistributed back to
the ER. Staining of unfixed nonpermeabilized cells with
anti-VSVG antibodies showed reduced levels of surface
staining for the chimeras as compared with the parent
molecule (data not shown). Quantitation of surface ex-
pression by flow cytometry (Fig. 6) revealed that, although
the percentage of cells expressing detectable levels of sur-
face staining were similar (z7–9%), VSVG–Leu15 exhib-
ited mean fluorescence intensity levels significantly lower
than VSVGtsO45 (60% of tsO45). VSVG–IL2R showed
an intermediate level of cell surface expression (75% of
tsO45). Since total expression levels were equivalent when
cells were stained in the presence of detergent (data not
shown), this result indicates that significantly less VSVG–
Leu15 (and VSVG–IL2R) had been delivered to the plasma
membrane than parental VSVGtsO45. The remainder
(z40% of VSVG–Leu15 and z25% of VSVG–IL2R) had
presumably redistributed to the ER (Fig 5, middle), since
Golgi staining was evident for the Leu15 (and IL2R) chi-
meras, but not the parent G protein when the temperature
was subsequently lowered from 408 to 328C (Fig. 5, right).
As these experiments were performed in the presence of
cycloheximide, this material must have originated from
previously redistributed Golgi pools.
The observation that VSVGtsO45, –IL2R, and –Leu15
were delivered from the ER to the Golgi complex upon
a shift from 408 to 328C (or 188C) at approximately equi-
valent rates (data not shown; Fig. 5, left) implies that it
is their transport through the Golgi complex, rather than
exit from the ER, that is slowed when compared with
VSVGtsO45. When combined with the recycling and bio-
chemical processing data, these results suggest that whereas
proteins rapidly transported through the Golgi complex
(VSVGtsO45) continue to the cell surface after the tem-
perature shift, proteins that are either stably retained
(VSVG–KDELR, –KDELRm, and –TGN38) or slowly
Table I. Inhibition of Retrograde Membrane Traffic
Treatment 32° to 40°C BFA
Control — —
2ATP 11 11
AlF4 1* 1*
Forskolin 11 11
W7 11
Wortmannin 11 ‡
ConcanamycinB 11 1
Monensin — 11
CHO cells stably expressing VSVG–TGN38 were incubated with the indicated drugs
or pharmacological treatments for 10 min at 32°C before shifting either to 40°C for 2 h,
or adding 1 mg/ml BFA and incubating at 32°C for 30 min. Refer to Materials and
Methods for concentrations and descriptions of the individual treatments. Cells were
fixed and double labeled with anti-VSVG antibodies and antiserum to the Golgi resi-
dent enzyme, mannosidase II. The redistribution of VSVG–TGN38 into the ER at
40°C, and VSVG–TGN38 and mannosidase II into the ER with BFA, is shown as (—)
for control cells. Full and partial inhibition of these redistributions are indicated by
(11) and (1), respectively. *Indicates VSVG–TGN38 becomes vesiculated in the
Golgi region; ‡indicates the redistribution of VSVG–TGN38 into the ER is partially
inhibited, whereas redistribution of mannosidase II is unaffected.
Figure 6. Surface staining of VSVG chimeras by flow cytometry.
COS cells were transiently transfected with 5 mg VSVGtsO45, or
the LEU15, IL2R, or KDELR wild-type chimeric plasmids, and
then maintained at 408C. At 40 h posttransfection, cycloheximide
was added, and cells were placed at 188C for 3 h, and then re-
turned to 408C for an additional 2 h. Intact cells were harvested
and stained on ice with anti-VSVG monoclonal antibodies, and
then with secondary FITC-conjugated anti–mouse IgG. Shown
is the surface-staining intensity (x-axis) measured for cells gated
for positive VSVGtsO45 surface expression (M1). Cell number
is plotted on the y-axis. Statistical analysis indicates significantly
higher mean fluorescence intensity for VSVGtsO45 (mean value
z451) than for the Leu15 (z274) and IL2R (z341) chimeras,
with the KDELR wild-type chimera (z43) serving as a negative
cell surface control. Parallel samples analyzed in the presence of
0.2% saponin determined total cellular staining and showed equi-
valent expression levels for each construct.Cole et al. Retrograde Transport from the Golgi to the ER 9
transported through the Golgi (VSVG–Leu15 and IL2R)
have the capacity to be retrieved to the ER.
Folding Properties of VSVG Fusion Proteins in the ER 
and Golgi Complex
The redistribution of VSVG chimeras into the ER after a
temperature shift to 408C is presumed to be due to mis-
folding/retention of the G protein ectodomain within the
ER as these molecules recycle from the Golgi complex. This
interpretation was tested using the conformation-specific
VSVG antibody, I14 (Lefrancois and Lyles; 1982), which
has previously been used to detect folded, but not mis-
folded, VSVG molecules (Doms et al., 1988, 1989; Macha-
mer et al., 1990). As shown in Fig. 7 (a), I14 staining of
VSVG–TGN38 in stably expressing CHO cells gave a pri-
marily Golgi staining pattern at 328C. As in COS cells, this
staining coincided with b-COP (data not shown) and the
Golgi enzyme mannosidase II (Fig. 7 b). After short peri-
ods at 408C, before VSVG–TGN38 had redistributed into
the ER (data not shown), or under conditions where its re-
distribution was inhibited by ATP depletion (Fig. 7 e),
VSVG–TGN38 staining by I14 antibodies was still de-
tected in the Golgi complex. This indicated that VSVG–
TGN38 did not significantly misfold when it was in the
Golgi complex at 408C, even after several hours during
which recycling was inhibited (e.g., with ATP depletion).
Under conditions where VSVG–TGN38 was trans-
ported into the ER (i.e., upon longer periods at 408C), spe-
cific staining for VSVG–TGN38 by I14 was lost (Fig. 7 c),
but reappeared when cells were shifted from 408 back to
328C for 10 min under conditions where export from the
ER was blocked (e.g., ATP depletion; Fig. 7 g). Loss of I14
staining of VSVG–TGN38 in the ER at 408, but not at
328C, was also observed in cells with Golgi proteins redis-
tributed into the ER with BFA (Doms et al., 1989; Lippin-
cott-Schwartz et al., 1989; Fig. 7, compare i with k). These
results are consistent with the idea that the mechanism for
the accumulation of the VSVG chimeras within the ER in
cells transfected at 408C and during the 408C temperature
shift is due to misfolding of the G protein ectodomain in
this compartment. Moreover, changes in conformation of
VSVG–TGN38 leading to loss of labeling by I14 antibod-
ies appeared to occur only after the protein had redistrib-
uted into the ER.
Biochemical analysis provided further evidence that
misfolding of the chimeras at 408C occurred only after the
proteins had redistributed into the ER. A cell fraction-
ation procedure to separate ER from Golgi membranes
was developed to analyze misfolding in vitro. COS cells
expressing VSVG–TGN38 were metabolically labeled with
[35S]methionine at the permissive temperature to generate
labeled proteins in both the ER and Golgi complex. Cells
were gently scraped, pelleted, and then a postnuclear su-
pernatant was layered over a continuous 0–26% OptiPrep
gradient (refer to Materials and Methods). Fractions were
collected and analyzed for the distribution of ER (ribo-
phorin) and Golgi (galactosyltransferase) membrane mark-
ers (Fig. 8 a). Separate ER and Golgi fractions were
pooled and aliquots were incubated at either 328 or 408C
for 60 min to assess the capacity of the individual mem-
brane compartments to misfold VSVG–TGN38. After sol-
Figure 7. Analysis of cycling using conformation-sensitive anti-
bodies. CHO cells stably expressing VSVG–TGN38 were treated
as indicated and stained with conformation-sensitive I14 antibod-
ies to VSVG (a, c, e, g, i, and k), and antibodies to the Golgi en-
zyme, mannosidase II (b, d, f, h, j, and l). Images were acquired
on a Zeiss laser scanning confocal microscope. Notice the com-
plete lack of I14 staining in cells treated at 408C (e), but not when
recycling was inhibited (c). The brightness of the cells in e and k
was artificially enhanced to show the cell outline. Bar, 10 mm.The Journal of Cell Biology, Volume 140, 1998 10
ubilization at the indicated temperatures, VSVG–TGN38
was immunoprecipitated with either polyclonal antibodies
that recognize both folded and misfolded G protein, or
with the conformation-sensitive I14 antibody.
As shown in Fig. 8 (b), polyclonal anti-VSV recognized
VSVG–TGN38 in both ER and Golgi fractions regardless
of the incubation temperature. I14 was also able to precip-
itate VSVG–TGN38 from fractions containing Golgi and
ER membranes at 328C. However, incubation at 408C dra-
matically reduced the ability of I14 to recognize VSVG–
TGN38 from ER fractions, whereas immunoprecipitation
from Golgi fractions was only slightly affected. Therefore,
consistent with de Silva et al. (1990), only the ER appears
to contain specific factors capable of misfolding tsO45-
containing chimeras at the nonpermissive temperature.
We next determined whether we could observe the recy-
cling/misfolding process in intact cells biochemically. COS
cells expressing VSVG–TGN38 were metabolically la-
beled at 408C, chased in unlabeled medium at 328C for ei-
ther 5 min, where the majority of newly synthesized mole-
cules should still be in the ER, or for 2 h to accumulate the
labeled chimera in the Golgi complex, before shifting back
to 408C for an additional period of time. After solubiliza-
tion at the indicated temperatures, VSVG–TGN38 was
immunoprecipitated with either polyclonal or conforma-
tion-sensitive I14 antibodies. As shown in Fig. 9, whereas
VSVG–TGN38 could fold completely after a 5-min chase
at 328C, only 25% could be immunoprecipitated with I14
after a subsequent shift to 408C. Thus, folded VSVG–
TGN38 can rapidly misfold when it is contained within the
environment of the ER. However, when VSVG–TGN38
had been chased for 2 h at 328C and then shifted to 408C,
.80% remained properly folded after a 10-min incubation
at 408C. It is likely that the remaining misfolded fraction
represents a population of VSVG–TGN38 molecules that
has not left the ER. Therefore, as with the parent G protein
(de Silva et al., 1990), and consistent with the in vitro data
(Fig. 8), the chimera becomes resistant to misfolding when
it is delivered to the Golgi complex. If, after a 2-h chase at
328C, labeled cells were shifted to 408C for increasing peri-
ods of time, the amount of I14 precipitable material de-
creased, whereas material recognized by polyclonal anti-
VSV remained unchanged (Fig. 9). The temporal loss of
I14 immunoreactivity, therefore, correlated with recycling
and subsequent misfolding of VSVG–TGN38 as it redis-
tributed into the ER. This misfolding could be reversed by
a subsequent short incubation at 328C (Fig. 9). Thus, the
fusion proteins do not appear to misfold in the Golgi com-
Figure 8. Fractionation of ER and Golgi
membranes and misfolding in vitro. (A)
COS cells transfected with VSVG–TGN38
were labeled with [35S]methionine, chased
to generate labeled molecules in both the
ER and Golgi complex, and then homoge-
nized and fractionated on a 0–26% Op-
tiprep gradient, as described in Materials
and Methods. Fractions were analyzed for
the presence of specific markers; ribo-
phorin (ER), and galactosyltransferase ac-
tivity (Golgi). (B) Pooled ER and Golgi
fractions were aliquoted into equal vol-
umes and incubated at either 328 or 408C
for 60 min. Membranes were lysed at the
indicated temperatures, placed on ice, and
immunoprecipitated with polyclonal anti-
VSV antiserum or conformation-sensitive
anti-VSVG I14 antibodies. Precipitates
were analyzed by SDS-PAGE and scan-
ning densitometry. Notice the relative
ability of I14 antibodies to recognize
VSVG–TGN38 from Golgi, but not from
ER, fractions at 408C.Cole et al. Retrograde Transport from the Golgi to the ER 11
plex upon a shift to 408C, but only once they have recycled
into the ER.
Discussion
An Assay for Retrograde Traffic in Mammalian Cells
Retrograde transport of proteins and lipids from the Golgi
complex back to the ER is widely recognized as crucial for
proper functioning of the secretory pathway. Such retro-
grade flow maintains the surface area of the ER in the face
of extensive membrane outflow into the secretory path-
way (Wieland et al., 1987; Hoffman and Pagano, 1993), en-
sures the return of escaped ER resident proteins (Jackson
et al., 1993; Letourneur et al., 1994; Pelham, 1995), and
recycles membrane machinery involved in ER to Golgi
traffic (Lewis and Pelham, 1996; Rothman, 1996). The ex-
periments reported here suggest an additional role of ret-
rograde traffic: to periodically return Golgi-localized pro-
teins to the folding environment of the ER.
To examine whether proteins that have left the ER ever
return to its folding environment, we used a retrograde
transport assay based on the capacity of the ER to retain
misfolded proteins. We found that we could append the
entire temperature-sensitive ectodomain (z60 kD) of the
VSVGtsO45 to several Golgi proteins or targeting domains
without disrupting the thermoreversible characteristics of
VSVGtsO45, or the ability of the modified proteins to tar-
get and function properly. We reasoned that if these
Golgi-localized chimeras were recycled through the ER,
they should become trapped and accumulate within the
ER over time at the nonpermissive temperature. This would
be due to the unique capacity of the ER to retain mis-
folded VSVGtsO45 (Doms et al., 1987; de Silva et al., 1990).
The rate and extent such proteins accumulate in the ER,
losing their normal localization, should reflect their capac-
ity for recycling.
Cycling Dynamics of VSVG Fusion Proteins
Addition of the VSVGtsO45 ectodomain to KDELR,
KDELRm, and domains of TGN38 and IL2R conferred
the thermosensitive folding characteristics of VSVGtsO45
to these proteins/targeting domains, resulting in their mis-
folding and retention in the ER after biosynthesis at 408C.
It had no effect, however, on proper folding and targeting
of these proteins at the permissive temperature. At 328C,
VSVG–KDELR gave a mixed Golgi/ER distribution and
remained endo H sensitive, consistent with the idea that
the KDELR cycles between the Golgi and ER (Lewis and
Pelham, 1992; Tang et al., 1993), and is primarily localized
to the proximal regions of the Golgi complex (Griffiths et al.,
1994). In contrast, the VSVG–KDELRm chimera showed
little ER staining, had sugar modifications characteristic of
the trans-Golgi/TGN, and showed extensive colocalization
with the TGN marker protein, furin. Thus, the single
amino acid change (Asp to Asn at position 193) within
KDELR is sufficient to alter the distribution of this mole-
cule within the Golgi complex. VSVG–TGN38 localized to
the Golgi complex at 328C and could be redistributed to
the cell surface by overexpression of additional molecules
that contained TGN-targeting signals (data not shown).
This is consistent with the results of Humphrey et al. (1993),
and is likely due to saturation of the sorting machinery re-
quired to maintain TGN localization (Marks et al., 1996).
Thus, VSVG–TGN38 was likely targeted to the TGN.
In cells in which the VSVGtsO45 fusion proteins or
parental VSVGtsO45 were localized to the Golgi com-
plex, a temperature shift to 408C for 2 h resulted in the re-
distribution of VSVG–KDELR, VSVG–KDELRm, and
VSVG–TGN38 into the ER. For VSVG–KDELR, this oc-
curred with a t1/2 of 20 min, whereas for VSVG–TGN38 and
VSVG–KDELRm, it was z60 and 75 min, respectively.
VSVGtsO45, by contrast, did not redistribute to the ER,
but was delivered to the cell surface. The changes in distri-
bution of the chimeras did not require new protein synthesis,
indicating that their accumulation within the ER was not due
to newly synthesized material, but represented a preexist-
ing population that had recycled from the Golgi complex.
Recycling Does Not Appear to Be Induced by
Misfolded Proteins
The extensive redistribution of VSVG–KDELR, VSVG–
KDELRm, and VSVG–TGN38 into the ER after 2 h of
shift to the nonpermissive temperature was surprising. Al-
though KDELR is thought to constitutively cycle between
the ER and Golgi complex (Lewis and Pelham, 1992), and,
Figure 9. The relationship between misfolding and recycling in
intact cells. COS cells expressing VSVG–TGN38 were pulse la-
beled at 408C, and then chased in unlabeled medium at 328C for
either 5 min or 2 h. After each chase point, equal aliquots were
shifted back to 408C for an additional 10 min. Cells were solubi-
lized and immunoprecipitated with polyclonal anti-VSV or mon-
oclonal I14 antibodies. Whereas labeled material within the ER is
sensitive to misfolding, material chased into the Golgi becomes
resistant. Continued incubation at 408C leads to a decrease in the
percentage of folded but not total VSVG–TGN38. A subsequent
shift back to 328C permits refolding of VSVG–TGN38. Notice
that a wild-type VSVG–TGN38 chimera is totally resistant to mis-
folding at 408C. Quantitation reflects the average of two indepen-
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therefore would be predicted to redistribute to the ER in
this assay, there is no evidence for recycling of KDELRm
and TGN38, which are believed to be relatively stable res-
idents of the Golgi complex. This raises the question,
therefore, whether the observed retrograde transport of
these molecules reflects constitutive recycling (indepen-
dent of the VSVG lumenal tag), or is artificially induced
by attachment of the lumenal domain of VSVGtsO45.
Misfolding of this domain at 408C in the Golgi complex
could be recognized for retrieval by a chaperone-like mol-
ecule such as BiP that has leaked out of the ER (Ham-
mond and Helenius, 1994). Several lines of evidence, how-
ever, suggest that retrieval was not activated within the
Golgi complex, and that misfolding occurred within ER
and not Golgi membranes. First, parental VSVGtsO45
that had accumulated within the Golgi complex was not
retrieved to the ER upon a shift to 408C, but was delivered
solely to the cell surface. Since it contains the thermosensi-
tive ectodomain similar to all fusion proteins, partial deliv-
ery back to the ER upon a temperature shift should have
been expected under a chaperone-retrieval model. Sec-
ond, our data indicated that misfolding occurred within
ER and not Golgi membranes, as assessed with confor-
mation-sensitive antibodies, in both isolated membrane
fractions (Fig. 8) and intact cells (Fig. 9). Third, inhibiting
redistribution into the ER by ATP depletion, etc. did not
reduce the ability to stain for the chimeras in the Golgi
complex with conformation-specific antibodies even after
2 h at 408C, whereas staining in the ER was completely
eliminated (Fig. 7). Finally, proteins involved in the as-
sisted folding of newly synthesized secretory and mem-
brane proteins, such as BiP, protein disulfide isomerase,
and calnexin, are almost exclusively localized to the ER,
with little or no escape into the Golgi complex (Akagi et
al., 1989; Bole et al., 1989; Rajagopalan et al., 1994). It is
unlikely that under normal conditions escaped chaperones
could have retrieved the entire Golgi-localized pools of
VSVG–KDELR, –KDELRm, and –TGN38 within 2 h after
a shift to the nonpermissive temperature (for VSVG–KDELR,
complete redistribution occurred within 20–40 min).
Thus, the redistribution into the ER observed at 408C
did not likely occur by activating retrieval via misfolding
of the VSVG chimeras within the Golgi complex. How-
ever, we cannot rule out the possibility that subtle confor-
mational changes, such as transient unfolding or tempo-
rary aggregation, may influence the trafficking of these
molecules. Furthermore, since the epitope recognized by
the I14 antibody used in this study is one that forms late in
the VSVG folding process (Doms et al., 1988), it is un-
likely that significant conformational changes lead to un-
folding of the chimeras within the Golgi complex at 408C.
Based on the above results, the simplest interpretation for
redistribution of the VSVG chimeras into the ER upon
shift to the nonpermissive temperature is that it reflects a
constitutive recycling pathway followed by these mole-
cules. At 408C, the chimeras become trapped in the ER
due to misfolding of the VSVG ectodomain in the unique
lumenal environment of the ER.
Retrograde Traffic May Not Require Specific Signals
If the VSVG chimeras are indeed constitutively recycling
from the Golgi to the ER, an important question is
whether their retrieval is mediated by specific retrieval sig-
nals located on the attached proteins or targeting domains,
or is due to nonselective or bulk-flow transport. Many
membrane proteins known to cycle between the ER and
Golgi complex contain dibasic signals within their cyto-
plasmic domains (Jackson et al., 1993; Gaynor et al., 1994;
Schutze et al., 1994; Itin et al., 1995) that are thought to be
recognized by a sorting machinery that mediates their re-
trieval from the Golgi complex (Letourneur et al., 1994).
The finding that VSVG–TGN38, which lacks known Golgi
to ER retrieval signals within its cytoplasmic tail (Luzio
et al., 1990), and VSVG–KDELRm, which is defective for
KDEL-mediated retrieval (Townsley et al., 1993), un-
dergo retrograde transport to the ER, raises the question
of whether membrane cycling between the Golgi complex
and ER is an inherent feature of Golgi-localized proteins
that does not require specific retrieval motifs.
It has been noted that many Golgi resident proteins
have shorter transmembrane domains than molecules tar-
geted to the cell surface (Bretscher and Munro, 1993). A
general lipid sorting model was proposed for Golgi protein
localization involving partitioning into thinner regions of
the Golgi bilayer and exclusion from forward moving
transport intermediates (Bretscher and Munro, 1993; Munro,
1995). To test whether Golgi retention of proteins with
shortened transmembrane domains correlates with Golgi
to ER recycling activity, we replaced the 23–amino acid
transmembrane domain of VSVGtsO45 with a synthetic
domain of 15 leucines (Munro, 1995). Cells expressing
VSVG–Leu15 at 328C showed a significant accumulation
within the Golgi complex as the protein was slowly trans-
ported through the Golgi to the plasma membrane. When
these cells were shifted to 408C, a significant proportion of
VSVG–Leu15 redistributed to the ER rather than to the
plasma membrane. In contrast, under the same conditions,
VSVGtsO45 was delivered solely to the plasma membrane.
This suggests that itinerant proteins moving rapidly
through the Golgi complex (VSVGtsO45) are less avail-
able for recycling than those that move more slowly
(VSVG–IL2R  . VSVG–Leu15), and raises the interesting
possibility that at least for proteins en route to the cell sur-
face, anterograde and retrograde transport coexist within
the Golgi complex as mutually competing processes.
Since replacing the transmembrane domain of VSVGtsO45
with a shorter hydrophobic domain would be expected to
primarily influence the lipid environment with which this
protein interacts, rather than generate a novel retrieval
motif, these results support a relationship between lipid
partitioning and retrograde traffic. The Golgi complex is
known to be the site of major lipid transitions between the
ER and plasma membrane (Orci et al., 1981; van Meer,
1989; Munro, 1995). Changes in lipid composition across
the Golgi stacks (Bretscher and Munro, 1993) may estab-
lish a gradient of recycling activity, such that cis-Golgi pro-
teins would become partitioned within membranes with
high levels of recycling activity. This activity would then
decrease across the Golgi stack by distilling back to earlier
cisternae or to the ER (Rothman and Wieland, 1996).
trans-Golgi proteins would tend to partition into mem-
branes with less recycling activity, and recycle to the ER
more slowly.Cole et al. Retrograde Transport from the Golgi to the ER 13
An increasing body of evidence suggests that Golgi resi-
dent proteins cycle within the Golgi complex (Johnston et
al., 1994; Hoe et al., 1995; Harris and Waters, 1996). Since
Golgi enzymes contain short cytosolic domains lacking
conventional Golgi to ER retrieval signals suggests that al-
ternative mechanisms for recycling of these proteins exist.
If such cycling were mediated by a lipid-partitioning mech-
anism, it may extend not only within the Golgi complex,
but all the way back to the ER, a view that is consistent
with our results. Specific retrieval determinants (e.g.,
KDEL and KKXX; Letourneur et al., 1994; Pelham, 1995)
may increase recycling efficiency of selected proteins, but
the overall extent of retrograde transport within the Golgi
complex and back to the ER would be a constitutive pro-
cess that operates independently of these types of signals.
A recent study by Johannes et al. (1997) supports this
thinking and raises questions regarding the role of puta-
tive retrieval signals. Shiga toxin B fragments carrying ei-
ther wild-type or mutated KDEL signals were found to be
delivered from the cell surface through the Golgi complex
to the ER with equal kinetics. This indicates that the
KDEL signal itself is not likely to be important for retro-
grade transport per se, but rather for retention within the
ER (Johannes et al., 1997).
Implications
An important function of Golgi protein recycling to the
ER may be to allow Golgi proteins to be periodically ex-
posed to the folding machinery in the ER where they
could undergo further modification/repair and/or degrada-
tion. The ER is known to be unique in its content of fold-
ing enzymes and chaperones that catalyze dynamic fold-
ing/unfolding reactions (Gething and Sambrook, 1992).
Such reactions are necessary for folding and assembly of
newly synthesized proteins into functional, transport-com-
petent complexes, and ensure that nonfunctional and in-
complete protein complexes do not leave the ER (Hurtely
and Helenius, 1989; Doms et al., 1993). Given that the ER
is the major compartment where such misfolding and re-
tention occurs, recycling to the ER could be important for
monitoring the fidelity of proteins that spend most of their
lifetime in distal secretory compartments. The fact that
properly folded VSVGtsO45 chimeras recycled back to
the ER and became quickly misfolded and trapped at non-
permissive temperatures supports this hypothesis.
A major consequence of constitutive cycling of Golgi
proteins (and lipids) would be its contribution to the dy-
namic nature of the Golgi complex. If the bulk of Golgi
membrane components constitutively recycle to the ER,
then the integrity of the Golgi complex will be critically
dependent upon (and likely regulated by) the return of
such components from the ER. Consistent with this think-
ing, virtually all conditions that interfere with delivery of
proteins from the ER into the Golgi complex, including
treatments with BFA, ilimaquinone, okadaic acid, and
overexpression of particular rab mutants, result in dis-
persal of Golgi membranes (Lippincott-Schwartz et al.,
1989; Lucocq, 1992; Takizawa et al., 1993; Wilson et al.,
1994; Martinez et al., 1997). One well-studied example is
microtubule disruption by nocodazole (Cole et al., 1996),
which blocks translocation of pre-Golgi structures into the
centrosomal region where the Golgi complex normally re-
sides (Saraste and Svensson, 1991; Presley et al., 1997).
Golgi enzymes in nocodazole-treated cells redistribute
gradually over several hours to ER exit sites, giving rise to
Golgi fragmentation (Cole et al., 1996). Since ERGIC-53,
a protein which rapidly and constitutively cycles between
the ER and Golgi (Itin et al., 1995), redistributes within 15
min from the Golgi to these sites after first moving through
the ER, the slower accumulation of Golgi resident compo-
nents to the same ER exit sites in nocodazole-treated cells
has been proposed to reflect constitutive bulk cycling of
Golgi components back to the ER (Cole et al., 1996).
The idea that all Golgi components, including Golgi en-
zymes, are suggested to recycle periodically through the
ER does not imply that the ER/Golgi system is a uniform
mixing compartment. Differences in recycling rates, as well
as sorting mechanisms that effectively segregate Golgi en-
zymes, may prevent full spatial and temporal contact of
Golgi enzymes with potential substrates. Thus, all Golgi
resident proteins may not become uniformly modified. It
is evident, however, that significant mixing does occur
within the Golgi. Many proximal Golgi proteins possess
distal Golgi modifications (Moreman and Touster, 1985;
Johnson et al., 1994; Harris and Waters, 1995), and distal
Golgi enzymes can recycle to early Golgi compartments
(Hoe et al., 1995). Evidence of biochemical modification
does not verify the location where the processing event oc-
curs, however; only that enzyme and substrate (and sugar
nucleotide donor, for example) associate within a permis-
sive processing environment. Therefore, it cannot be ruled
out that evidence of a particular Golgi modification actu-
ally reflects recycling of Golgi enzymes to earlier Golgi
compartments, rather than transport of substrate forward
into more distal Golgi compartments. Based on the work
presented here, it is not unreasonable to extend this think-
ing to suggest that certain ER proteins may acquire Golgi
modifications via recycling of Golgi enzymes, even if they
never actually leave the ER.
In summary, we have developed a novel assay for moni-
toring Golgi to ER retrograde transport in living cells that
is capable of addressing the extent, specificity, and bio-
chemical requirements of protein transport through this
pathway. Results with this assay suggest entry into the ret-
rograde pathway is not exclusively signal-mediated, and
may be an inherent property of proteins distributed within
Golgi membranes. If correct, the overall magnitude of
Golgi to ER retrograde traffic would be much greater than
previously expected, with important implications for our
understanding of Golgi maintenance and biogenesis.
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